Negative Regulation of Beta Enolase Gene Transcription in Embryonic Muscle is Dependent Upon a Zinc Finger Factor That Binds to the G-rich Box Within the Muscle-specific Enhancer
Overview
Affiliations
We have previously identified a muscle-specific enhancer within the first intron of the human beta enolase gene. Present in this enhancer are an A/T-rich box that binds MEF-2 protein(s) and a G-rich box (AGTGGGGGAGGGGGCTGCG) that interacts with ubiquitously expressed factors. Both elements are required for tissue-specific expression of the gene in skeletal muscle cells. Here, we report the identification and characterization of a Kruppel-like zinc finger protein, termed beta enolase repressor factor 1, that binds in a sequence-specific manner to the G-rich box and functions as a repressor of the beta enolase gene transcription in transient transfection assays. Using fusion polypeptides of beta enolase repressor factor 1 and the yeast GAL4 DNA-binding domain, we have identified an amino-terminal region responsible for the transcriptional repression activity, whereas a carboxyl-terminal region was shown to contain a potential transcriptional activation domain. The expression of this protein decreases in developing skeletal muscles, correlating with lack of binding activity in nuclear extract from adult skeletal tissue, in which novel binding activities have been detected. These results suggest that in addition to the identified factor, which functionally acts as a negative regulator and is enriched in embryonic muscle, the G-rich box binds other factors, presumably exerting a positive control on transcription. The interplay between factors that repress or activate transcription may constitute a developmentally regulated mechanism that modulates beta enolase gene expression in skeletal muscle.
The liver clock tunes transcriptional rhythms in skeletal muscle to regulate mitochondrial function.
Sica V, Sato T, Tsialtas I, Hernandez S, Chen S, Baldi P bioRxiv. 2025; .
PMID: 39896530 PMC: 11785164. DOI: 10.1101/2025.01.17.633623.
Loss of ZNF148 enhances insulin secretion in human pancreatic β cells.
de Klerk E, Xiao Y, Emfinger C, Keller M, Berrios D, Loconte V JCI Insight. 2023; 8(11).
PMID: 37288664 PMC: 10393241. DOI: 10.1172/jci.insight.157572.
β Cell-specific deletion of Zfp148 improves nutrient-stimulated β cell Ca2+ responses.
Emfinger C, de Klerk E, Schueler K, Rabaglia M, Stapleton D, Simonett S JCI Insight. 2022; 7(10).
PMID: 35603790 PMC: 9220824. DOI: 10.1172/jci.insight.154198.
Expression and differential regulation of human TERRA at several chromosome ends.
Feretzaki M, Nunes P, Lingner J RNA. 2019; 25(11):1470-1480.
PMID: 31350341 PMC: 6795134. DOI: 10.1261/rna.072322.119.
Transcription factor ZNF148 is a negative regulator of human muscle differentiation.
Bakke J, Wright W, Zamora A, Ong S, Wang Y, Hoyer J Sci Rep. 2017; 7(1):8138.
PMID: 28811660 PMC: 5557752. DOI: 10.1038/s41598-017-08267-5.